Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Breast Cancer: Pathology, Diagnosis and Treatment"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".
Deadline for manuscript submissions: 20 July 2023 | Viewed by 3476
Special Issue Editor
E-Mail Website1 Website2
2. Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center—IRCCS, Humanitas Cancer Center, Via Manzoni 56, Rozzano, 20089 Milan, Italy
Interests: breast neoplasms; predictive and prognostic factors; radiomics; microbiota; metabolomics; neurological comorbidities; dietary patterns
Special Issue Information
Thanks to improvements in more accurate diagnostic tools and widespread screening programs, the incidence of breast cancer (BC) has steadily increased over the past 20 years, making it the most common female cancer, with more than 2.2 million new cases per year. At the same time, research advances in successful therapies have led to a decline in mortality rates and an increase in prevalence, with BC now affecting more than 7.7 million people.
BC risk factors include advanced age, obesity, alcohol abuse, smoking and physical inactivity, higher exposure to estrogen, and postmenopausal hormone replacement therapy. Although most cases of BC are sporadic, a third can be attributed to familial (20–30%) or hereditary (5–10%) causes.
In recent decades, basic and translational studies have led to new biological insights, that have contributed to the improvement of diagnostic and treatment options for BC, as well as to the development of predictive and prognostic biomarkers useful to avoid unnecessary treatments. Furthermore, several clinical trials have shown the possible (old and new) toxicities of cancer treatments, suggesting the best management strategies in clinical practice. However, BC management, due to the highly heterogeneity of the disease, is still a significant challenge in research.
Dr. Rita De Sanctis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- breast cancer
- Luminal A/B
- triple negative
- CDK4/6 inhibitors
- multigene assays
- antibody-drug conjugate